JP2010535466A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535466A5
JP2010535466A5 JP2010504369A JP2010504369A JP2010535466A5 JP 2010535466 A5 JP2010535466 A5 JP 2010535466A5 JP 2010504369 A JP2010504369 A JP 2010504369A JP 2010504369 A JP2010504369 A JP 2010504369A JP 2010535466 A5 JP2010535466 A5 JP 2010535466A5
Authority
JP
Japan
Prior art keywords
acnpv
pcap
cap
pfcsp
vietnam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504369A
Other languages
English (en)
Japanese (ja)
Other versions
JP5409605B2 (ja
JP5409605B6 (ja
JP2010535466A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010504369A priority Critical patent/JP5409605B6/ja
Priority claimed from PCT/JP2008/064503 external-priority patent/WO2009020236A2/en
Publication of JP2010535466A publication Critical patent/JP2010535466A/ja
Publication of JP2010535466A5 publication Critical patent/JP2010535466A5/ja
Publication of JP5409605B2 publication Critical patent/JP5409605B2/ja
Application granted granted Critical
Publication of JP5409605B6 publication Critical patent/JP5409605B6/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504369A 2007-08-07 2008-08-06 新規ウイルスベクター Expired - Fee Related JP5409605B6 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010504369A JP5409605B6 (ja) 2007-08-07 2008-08-06 新規ウイルスベクター

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007205785 2007-08-07
JP2007205785 2007-08-07
JP2010504369A JP5409605B6 (ja) 2007-08-07 2008-08-06 新規ウイルスベクター
PCT/JP2008/064503 WO2009020236A2 (en) 2007-08-07 2008-08-06 Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene

Publications (4)

Publication Number Publication Date
JP2010535466A JP2010535466A (ja) 2010-11-25
JP2010535466A5 true JP2010535466A5 (OSRAM) 2011-08-18
JP5409605B2 JP5409605B2 (ja) 2014-02-05
JP5409605B6 JP5409605B6 (ja) 2014-03-26

Family

ID=

Similar Documents

Publication Publication Date Title
CL2007001992A1 (es) Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege
HRP20192202T1 (hr) Acc inhibitori i njihove upotrebe
JP2012087153A5 (OSRAM)
JP2013510216A5 (OSRAM)
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
JP2013515360A5 (OSRAM)
JP2009524695A5 (OSRAM)
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
JP2015525757A5 (OSRAM)
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
JP2009108025A5 (OSRAM)
WO2008154234A3 (en) Extended release formulation of nevirapine
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
BR112012013199A2 (pt) composto, composição farmacêutica, e , uso de um composto
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
JP2009292763A5 (OSRAM)
BR112015021769A2 (pt) composições farmacêuticas compreendendo um agente ativo
SMT202500145T1 (it) Co-cristallo di ketoprofene e sua preparazione, composizioni farmaceutiche comprendenti lo stesso e relativi usi
EP2672985A4 (en) CITRATE-FREE PHARMACEUTICAL COMPOSITIONS WITH ANAKINRA
JP2010535466A5 (OSRAM)
EP2369925A4 (en) FORMULATION ON L-ARGININE BASE FOR ORAL ABSORPTION